Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Bharat Parenterals Ltd.

Bharat Parenterals

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
05 06 2021 Audited Results
11 08 2021 Quarterly Results
30 10 2021 Quarterly Results
09 02 2022 Quarterly Results
28 05 2022 Audited Results
10 08 2022 Quarterly Results
12 11 2022 Quarterly Results
13 02 2023 Quarterly Results
20 05 2023 Audited Results & Quarterly Results & Final Dividend
09 08 2023 Quarterly Results
09 11 2023 Quarterly Results
13 02 2024 Quarterly Results
29 10 2024 Quarterly Results
03 02 2025 Quarterly Results
12 05 2025 Audited Results & Final Dividend
28 07 2025 A.G.M. & Quarterly Results
12 11 2025 Quarterly Results
30 01 2026 Quarterly Results

News

21-APR-2026

USFDA concludes inspection at Vadodara facility of Bharat Parenterals’ arm

At the conclusion of the inspection, the USFDA has issued five observations under a Voluntary Action Indicated classification

02:22 PM
28-NOV-2025

FAMHP concludes EU GMP inspection at facility of Bharat Parenterals’ arm

The inspection was carried out at the Innoxel Lifesciences’ manufacturing facility from November 24, 2025 to November 28, 2025

03:30 PM
30-JUL-2025

Bharat Parenterals’ arm receives EIR from USFDA for Vadodara manufacturing facility

This follows the successful completion of the U.S. FDA inspection conducted from April 28 to May 2, 2025

04:10 PM
05-MAY-2025

Bharat Parenterals’ arm clears USFDA inspection at manufacturing facility in Vadodara

The inspection was conducted from April 28, 2025 to May 2, 2025

12:00 PM
29-JAN-2025

Bharat Parenterals receives order worth $27 million

The company has received order for the supply of high-demand pharmaceutical products over the next 18-24 months

09:22 AM
13-MAR-2024

Bharat Parenterals’ arm signs deal with two Global Complex Generic marketing companies

According to agreement, Innoxel Lifesciences will receive cumulative milestone payments of Rs 31 crore over the period of next three years

12:46 PM
17-JUN-2022

Bharat Parenterals gets nod to incorporate subsidiary company

The company is in the process of incorporation and yet to be incorporated

05:33 PM
Enrich money logo